Kidney Transplantation Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

1 Executive Summary

• 1.1 Market overview
  • Exhibit 01: Executive Summary – Chart on Market Overview
  • Exhibit 02: Executive Summary – Data Table on Market Overview
  • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary – Chart on Market by Geography
  • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
  • Exhibit 07: Executive Summary – Chart on Incremental Growth
  • Exhibit 08: Executive Summary – Data Table on Incremental Growth
  • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
  • Exhibit 13: Market segments

• 3.3 Market size 2023

• 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global kidney transplantation therapeutics market 2018 - 2022
  • Exhibit 18: Historic Market Size – Data Table on global kidney transplantation therapeutics market 2018 - 2022 ($ million)

• 4.2 Product Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ million)

• 4.3 Distribution Channel Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ million)

• 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

• 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

• 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

• 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

• 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

• 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

• 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

• 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
  • Exhibit 30: Chart on Product - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on Product - Market share 2023-2028 (%)

• 6.2 Comparison by Product
  • Exhibit 32: Chart on Comparison by Product
  • Exhibit 33: Data Table on Comparison by Product

• 6.3 Selective cytokine inhibitors - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Selective cytokine inhibitors - Market size and forecast 2023-2028 ($ million)
  • Exhibit 35: Data Table on Selective cytokine inhibitors - Market size and forecast 2023-2028 ($ million)
  • Exhibit 36: Chart on Selective cytokine inhibitors - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Selective cytokine inhibitors - Year-over-year growth 2023-2028 (%)

• 6.4 Immunosuppressive antimetabolites - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Immunosuppressive antimetabolites - Market size and forecast 2023-2028 ($ million)
  • Exhibit 39: Data Table on Immunosuppressive antimetabolites - Market size and forecast 2023-2028 ($ million)
  • Exhibit 40: Chart on Immunosuppressive antimetabolites - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Immunosuppressive antimetabolites - Year-over-year growth 2023-2028 (%)

• 6.5 Other drug - Market size and forecast 2023-2028
  • Exhibit 42: Chart on Other drug - Market size and forecast 2023-2028 ($ million)
  • Exhibit 43: Data Table on Other drug - Market size and forecast 2023-2028 ($ million)
  • Exhibit 44: Chart on Other drug - Year-over-year growth 2023-2028 (%)
  • Exhibit 45: Data Table on Other drug - Year-over-year growth 2023-2028 (%)

• 6.6 Market opportunity by Product
  • Exhibit 46: Market opportunity by Product ($ million)
  • Exhibit 47: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
  • Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%)

• 7.2 Comparison by Distribution Channel
  • Exhibit 50: Chart on Comparison by Distribution Channel
  • Exhibit 51: Data Table on Comparison by Distribution Channel

• 7.3 Hospital pharmacy - Market size and forecast 2023-2028
  • Exhibit 52: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 53: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 54: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)

• 7.4 Retail pharmacy - Market size and forecast 2023-2028
  • Exhibit 56: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 57: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 58: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 59: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)

• 7.5 Online pharmacy - Market size and forecast 2023-2028
  • Exhibit 60: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 61: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 62: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 63: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)

• 7.6 Market opportunity by Distribution Channel
  • Exhibit 64: Market opportunity by Distribution Channel ($ million)
  • Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Exhibit 67: Chart on Market share by geography 2023-2028 (%)
  • Exhibit 68: Data Table on Market share by geography 2023-2028 (%)

• 9.2 Geographic comparison
  • Exhibit 69: Chart on Geographic comparison
  • Exhibit 70: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)

• 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)

• 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

• 9.7 US - Market size and forecast 2023-2028
  • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)

• 9.8 China - Market size and forecast 2023-2028
  • Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)

• 9.9 Canada - Market size and forecast 2023-2028
  • Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)

• 9.10 Germany - Market size and forecast 2023-2028
  • Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)

• 9.11 UK - Market size and forecast 2023-2028
  • Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)

• 9.12 Market opportunity by geography
  • Exhibit 107: Market opportunity by geography ($ million)
  • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2023 and 2028

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption

• 11.4 Industry risks
  • Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
  • Exhibit 113: Vendors covered

• 12.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification

• 12.3 AbbVie Inc.
  • Exhibit 115: AbbVie Inc. - Overview
  • Exhibit 116: AbbVie Inc. - Product / Service
  • Exhibit 117: AbbVie Inc. - Key news
  • Exhibit 118: AbbVie Inc. - Key offerings

• 12.4 Asahi Kasei Corp.
  • Exhibit 119: Asahi Kasei Corp. - Overview
  • Exhibit 120: Asahi Kasei Corp. - Business segments
  • Exhibit 121: Asahi Kasei Corp. - Key news
  • Exhibit 122: Asahi Kasei Corp. - Key offerings
  • Exhibit 123: Asahi Kasei Corp. - Segment focus

• 12.5 Astellas Pharma Inc.
  • Exhibit 124: Astellas Pharma Inc. - Overview
  • Exhibit 125: Astellas Pharma Inc. - Product / Service
  • Exhibit 126: Astellas Pharma Inc. - Key news
  • Exhibit 127: Astellas Pharma Inc. - Key offerings

• 12.6 Bristol Myers Squibb Co.
  • Exhibit 128: Bristol Myers Squibb Co. - Overview
  • Exhibit 129: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 130: Bristol Myers Squibb Co. - Key news
  • Exhibit 131: Bristol Myers Squibb Co. - Key offerings

• 12.7 Dr Reddys Laboratories Ltd.
  • Exhibit 132: Dr Reddys Laboratories Ltd. - Overview
  • Exhibit 133: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibit 134: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibit 135: Dr Reddys Laboratories Ltd. - Segment focus

• 12.8 F. Hoffmann La Roche Ltd.
  • Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus

• 12.9 GlaxoSmithKline Plc
  • Exhibit 141: GlaxoSmithKline Plc - Overview
  • Exhibit 142: GlaxoSmithKline Plc - Business segments
  • Exhibit 143: GlaxoSmithKline Plc - Key news
  • Exhibit 144: GlaxoSmithKline Plc - Key offerings
  • Exhibit 145: GlaxoSmithKline Plc - Segment focus

• 12.10 Hansa Biopharma AB
  • Exhibit 146: Hansa Biopharma AB - Overview
  • Exhibit 147: Hansa Biopharma AB - Product / Service
  • Exhibit 148: Hansa Biopharma AB - Key offerings

• 12.11 Novartis AG
  • Exhibit 149: Novartis AG - Overview
  • Exhibit 150: Novartis AG - Business segments
  • Exhibit 151: Novartis AG - Key offerings
  • Exhibit 152: Novartis AG - Segment focus

• 12.12 Organ Recovery Systems Inc.
  • Exhibit 153: Organ Recovery Systems Inc. - Overview
  • Exhibit 154: Organ Recovery Systems Inc. - Product / Service
  • Exhibit 155: Organ Recovery Systems Inc. - Key offerings

• 12.13 Pfizer Inc.
  • Exhibit 156: Pfizer Inc. - Overview
  • Exhibit 157: Pfizer Inc. - Product / Service
  • Exhibit 158: Pfizer Inc. - Key news
  • Exhibit 159: Pfizer Inc. - Key offerings

• 12.14 Sanofi SA
  • Exhibit 160: Sanofi SA - Overview
  • Exhibit 161: Sanofi SA - Business segments
  • Exhibit 162: Sanofi SA - Key news
  • Exhibit 163: Sanofi SA - Key offerings
  • Exhibit 164: Sanofi SA - Segment focus

• 12.15 Strides Pharma Science Ltd.
  • Exhibit 165: Strides Pharma Science Ltd. - Overview
  • Exhibit 166: Strides Pharma Science Ltd. - Business segments
  • Exhibit 167: Strides Pharma Science Ltd. - Key offerings
  • Exhibit 168: Strides Pharma Science Ltd. - Segment focus

• 12.16 TFF Pharmaceuticals Inc.
  • Exhibit 169: TFF Pharmaceuticals Inc. - Overview
  • Exhibit 170: TFF Pharmaceuticals Inc. - Product / Service
  • Exhibit 171: TFF Pharmaceuticals Inc. - Key offerings

• 12.17 TolerogenixX GmbH
  • Exhibit 172: TolerogenixX GmbH - Overview
  • Exhibit 173: TolerogenixX GmbH - Product / Service
  • Exhibit 174: TolerogenixX GmbH - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist
  • Exhibit 175: Inclusions checklist
  • Exhibit 176: Exclusions checklist

• 13.3 Currency conversion rates for US$
  • Exhibit 177: Currency conversion rates for US$

• 13.4 Research methodology
  • Exhibit 178: Research methodology
  • Exhibit 179: Validation techniques employed for market sizing
  • Exhibit 180: Information sources

• 13.5 List of abbreviations
  • Exhibit 181: List of abbreviations